Wells Fargo’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60.6K | Buy |
|
|||||
|
2025
Q1 | $65.3K | Buy |
|
|||||
|
2024
Q4 | $86.8K | Buy |
|
|||||
|
2024
Q3 | $36.7K | Sell |
|
|||||
|
2024
Q2 | $63.9K | Buy |
|
|||||
|
2024
Q1 | $26.2K | Buy |
|
|||||
|
2023
Q4 | $24.3K | Buy |
|
|||||
|
2023
Q3 | $29.5K | Sell |
|
|||||
|
2023
Q2 | $51.4K | Buy |
|
|||||
|
2023
Q1 | $1.9K | Buy |
|
|||||
|
2022
Q4 | $884 | Buy |
|
|||||
|
2022
Q3 | $1K | Sell |
|
|||||
|
2022
Q2 | $1K | Sell |
|
|||||
|
2022
Q1 | $113K | Sell |
|
|||||
|
2021
Q4 | $381K | Sell |
|
|||||
|
2021
Q3 | $581K | Buy |
|
|||||
|
2021
Q2 | $229K | Buy |
|
|||||
|
2021
Q1 | $105K | Sell |
|
|||||
|
2020
Q4 | $350K | Sell |
|
|||||
|
2020
Q3 | $394K | Buy |
|
|||||
|
2020
Q2 | $357K | Buy |
|
|||||
|
2020
Q1 | $0 | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $4K | Sell |
|
|||||
|
2019
Q1 | $21K | Sell |
|
|||||
|
2018
Q4 | $23K | Sell |
|
|||||
|
2018
Q3 | $372K | Buy |
|
|||||
|
2018
Q2 | $316K | Buy |
|
|||||
|
2018
Q1 | $229K | Sell |
|
|||||
|
2017
Q4 | $230K | Buy |
|
|||||
|
2017
Q3 | $190K | Buy |
|
|||||
|
2017
Q2 | $103K | Hold |
|
|||||
|
2017
Q1 | $74K | Hold |
|
|||||
|
2016
Q4 | $89K | Buy |
|